| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |